Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 4 , ISSUE 2 ( May-August, 2012 ) > List of Articles

RESEARCH ARTICLE

Beneficial Effects of Addition of Glucocorticoid during Induction of Ovulation by Letrozole in Polycystic Ovarian Syndrome

Maruf Siddiqui, Hosne Ara Baby, Mosammat Shahina Begum, Farzana Khan

Citation Information : Siddiqui M, Baby HA, Begum MS, Khan F. Beneficial Effects of Addition of Glucocorticoid during Induction of Ovulation by Letrozole in Polycystic Ovarian Syndrome. J South Asian Feder Obs Gynae 2012; 4 (2):85-89.

DOI: 10.5005/jp-journals-10006-1180

Published Online: 01-08-2014

Copyright Statement:  Copyright © 2012; The Author(s).


Abstract
PDF Share
  1. Current concept of PCOS. Baillieres clinical obstetrics and gynecology. Elsevier Science 1997;11:307-33.
  2. Management of polycystic ovarian dysfunction. In Steinberger E, Frajese G Steinberger A (Eds). Reproductive medicine, New York: Raven Press 1986;277-81.
  3. The relation between plasma testosterone and levels and the lengths of phases of the menstrual cycle. Fertil Steril 1979a;32:403-07.
  4. Effect of testosterone on human corpus luteum steroidogenesis in vitro. Fertil Steril 1979b;31:448-50.
  5. Incremental clomiphene therapy: A new method for treating persistent anovulation. Obst Gynec 1981;58: 535-42.
  6. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 1984;41:844-48.
  7. Induction of ovulation by combined clomiphene citrate and dexamethasone treatment in clomiphene citrate nonresponders. Eur J Obstet Gynecol Reprod Biol 1981;11:335-40.
  8. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 1984;42:76-81.
  9. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol 1983;146:602-05.
  10. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992;167:1807-12.
  11. Adrenal androgens in clinical medicine. New York: Academic Press 1989.
  12. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 1993; 76:1301-07.
  13. Androgens in the ovarian microenvironment. Sem Reprod Med 1986;4:89-100.
  14. 17 beta-oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Clin Endocrinol 1992;36:565-71.
  15. The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bulletin of the Johns Hopkins Hospital 1950; 86:249-52.
  16. The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: An attempt to correct its disordered hormonal pattern. J Clin Invest 1951;30:237-51.
  17. The use of cortisone in follicular phase disturbance. Fertil Steril 1953;4:49-62.
  18. Cortisone in the treatment of infertility. Fertil Steril 1956;7:203-12.
  19. Effect of prednisone on female infertility. Int J Fertility 1965;10:31-40.
  20. Polycystic ovarian disease: A report of 301 patients. Am J Obst and Gynaecol 1965; 93:994-1001.
  21. Fertil Steril 1979a;32:408-13.
  22. Hyperandrogenism and female infertility. In Crosignani PG Rubin B (Eds). Endocrinology of Human Infertility: New aspect. London: Academic Press 1981a;327-42.
  23. Testosterone levels in female partners of infertile couples. Am J Obst Gynacol 1979;133:133-38.
  24. Clomiphene-dexamethasone treatment of clomiphene-resistant women with and without the polycystic ovary syndrome. J Reprod Med 1992;37:215-18.
  25. Ovulation induction in clomiphene-resistant anovulatory women with normal dehydroepiandrosterone sulfate levels: beneficial effects of the addition of dexamethasone during the follicular phase. Fertil Steril 1996:484-86.
  26. Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynec 1982;60:497-501.
  27. Extended clomiphene citrate (CC) and prednisone for the treatment of chronic anovulation resistant to CC alone. Fertil Steril 1997;67:641-43.
  28. Ferdous J, Begum A, Quadir E. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome (PCOS). Fertil Steril 2009;92(3):853-57.
  29. Ovulation after glucocorticoids suppression of adrenal androgen in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. J Clin Endocrinol Metab. J Clin Endocrinol Metab 1999;84:946-50.
  30. Plasma testosterone stimulation-suppression dynamics in hirsute women. Correlation with long-term therapy. Am J Med 1973 54:195-200.
  31. Dexamethasone suppresses sex-hormone binding globulin. Fertil Steril 1988;49:66-70.
  32. Effect of acute and chronic androgen suppression by glucocorticoids on gonadotropin levels in hirsute women. J Clin Endocrinol Metab 1984;54:780-84.
  33. Effect of short-and long-term dexamethasone on 3-androstanediol glucronide in hirsute women. Fertil Steril 1986;46:227-31.
  34. The prognostic value of acute adrenal suppression and stimulation tests in hyperandrogenic women. Fertil Steril 1982;37:187-92.
  35. Long-term effects of nightly dexamethasone administration in patients with polycystic ovarian disease. J Clin Endocrinol Metab 1982;55:768-73.
  36. Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod 1993;49:1270-76.
  37. Androgens in the ovarian microenvironment. Sem Reprod Med 1986;4:89-100.
  38. 17 beta-oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Clin Endocrinol 1992;36:565-71.
  39. Clinical complications of corticosteroid therapy: A selected review. Med Clin North Am 1973;57:133-42.
  40. Complications of corticosteroid therapy. Am J Dis Children 1978;132:806-10.
  41. Glucocorticoid therapy. In: Felig P, Baxter JD, Broadus AE, Frohman LA (Eds). Endocrinology and Metabolism (2nd ed), pp 788-817. New York: McGraw-Hill.
  42. Androgen receptor controlled ovarian hyperstimulation in the primate ovary: Cellular localization, regulation and functional correction. J Clin Endocrinol Metab 1998;83:2479-85.
  43. Intraovarian regulation: The proposed role of insulin like growth factors. Ann NY Acad Aci 1993;687:10-12.
  44. Insulin like growth factors and ovarian follicular development. Endocr Rev 1992;13:641-69.
  45. Interface between extra and intraovarian factors in polycystic ovary syndrome (PCOS). Ann NY Acad Sci 1993;687:98-111.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.